Microplastics and Misinformation: What Science Really Says
November 12, 2025
Brand Name :
Akovaz
(United States) [Available] ,Emerphed
(United States) [Available] ,Rezipres
(United States) [Available]Synonyms :
Class :
Decongestants and Alpha-/Beta- Agonist
Dosage Forms & Strengths
Injectable-solution- (as sulfate)
50mg/mL
50mg/10mL (5mg/mL)
Injectable-solution- (as hydrochloride)
47mg/mL
23.5mg/5mL
Anesthesia induced: 5-10 mg IV bolus; to maintain BP repeat as needed Do not exceed a dose of 50 mg
Anesthesia induced: 5-10 mg IV bolus; to maintain BP repeat as needed Do not exceed a dose of 50 mg
4.7-9.4 mg IV bolus; repeat doses as needed
Do not exceed a dose of 47 mg
4.7-9.4 mg IV bolus; repeat doses as needed
Do not exceed a dose of 47 mg
25 mg-50 mg IM or subcutaneously or 5 mg-25 mg IV administered slowly repeat the dose in 5-10 minutes as needed
25 mg-50 mg IM or subcutaneously or 5 mg-25 mg IV administered slowly repeat the dose in 5-10 minutes as needed
25 mg-50 mg IM or subcutaneously or 5 mg-25 mg IV administered slowly repeat the dose in 5-10 minutes as needed
25 mg-50 mg IM or subcutaneously or 5 mg-25 mg IV administered slowly repeat the dose in 5-10 minutes as needed
25 mg-50 mg IM or subcutaneously or 5 mg-25 mg IV administered slowly repeat the dose in 5-10 minutes as needed
Dosage Forms & Strengths
Injectable-solution- (as sulfate)
50mg/mL
50mg/10mL (5mg/mL)
Injectable-solution- (as hydrochloride)
47mg/mL
23.5mg/5mL
Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours
Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours
Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours
Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours
Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours
Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours
Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours
When ephedrine is used together with mebhydrolin, ephedrine’s therapeutic effectiveness can be enhanced
ephedrine: they may enhance the serum concentration of CYP2D6 Inhibitors
ephedrine: they may enhance the serum concentration of CYP2D6 Inhibitors
ephedrine: they may enhance the serum concentration of CYP2D6 Inhibitors
ephedrine: they may enhance the serum concentration of CYP2D6 Inhibitors
ephedrine: they may enhance the serum concentration of CYP2D6 Inhibitors
the neuromuscular blocking activity of ephedrine may be increased
the therapeutic effect of ephedrine may be increased
May enhance the effects of the other by pharmacodynamic synergism
Adverse drug reactions:
Frequency Not Defined
Nausea
vomiting
Tachycardia
palpitations (thumping heart)
bradycardia
Dizziness
Restlessness
Pregnancy warnings:
AU TGA pregnancy category: A
Breastfeeding warnings:
The release of the drug into the human breastmilk is known
Pregnancy Categories:
Patient Information Leaflet
Generic Name: ephedrine
Pronounciation: e-FED-rin
Why do we use ephedrine?
ephedrine belongs to the class Decongestants and Vasopressors used to treat hypotension, acute asthma, myasthenia gravis, narcolepsy, and depression